Nephrotic Range Proteinuria Diagnosis and Management

Initial Evaluation and Referral

• The American College of Physicians recommends that all adults with nephrotic-range proteinuria require kidney biopsy to establish the underlying diagnosis, except when serum anti-phospholipase A2 receptor antibodies are positive, which is diagnostic of membranous nephropathy 1
• Obtain spot urine protein-to-creatinine ratio (PCR) to quantify proteinuria, as recommended by the National Kidney Foundation 2, 3
• Complete metabolic panel including serum creatinine, estimated GFR, electrolytes, glucose, and albumin should be completed before nephrology referral, as suggested by the American Society of Nephrology 1
• Urinalysis with microscopic examination for hematuria, pyuria, and cellular casts should be performed to assess for glomerulonephritis, as recommended by the European Renal Association 1
• Hepatitis B and C serology should be performed to exclude viral-associated glomerular disease, as recommended by the Centers for Disease Control and Prevention 1
• HIV testing should be performed to exclude HIV-associated nephropathy, as recommended by the World Health Organization 1
• Antinuclear antibody (ANA) should be tested to screen for systemic lupus erythematosus, as recommended by the American College of Rheumatology 1
• Complement levels (C3, C4) should be assessed to evaluate for complement-mediated glomerular disease, as recommended by the International Society of Nephrology 1
• Serum anti-phospholipase A2 receptor antibodies should be tested, as positive results can avoid unnecessary biopsy, as recommended by the National Institute of Diabetes and Digestive and Kidney Diseases 1

Imaging and Supportive Management

• Renal ultrasound should be performed to evaluate kidney size, structural abnormalities, and exclude obstruction, as recommended by the American Institute of Ultrasound in Medicine 1
• ACE inhibitor or ARB should be started for all patients with nephrotic-range proteinuria, regardless of blood pressure, as recommended by the American Heart Association 1
• Target blood pressure should be <125/75 mmHg in nephrotic-range proteinuria, as recommended by the American College of Cardiology 1
• Statin therapy should be considered for hyperlipidemia with target LDL-cholesterol <100 mg/dL, as recommended by the European Society of Cardiology 4

Special Populations

• Infants with congenital nephrotic syndrome should undergo whole-exome sequencing as first-line diagnostic, as recommended by the International Pediatric Nephrology Association 1
• Immediate referral to specialized tertiary pediatric nephrology center is recommended for infants with congenital nephrotic syndrome, as suggested by the American Academy of Pediatrics 1

Initial Treatment for Nephrotic Range Proteinuria

Diagnostic Approach and Treatment

• The Kidney International guidelines recommend that immunosuppressive therapy should not be started before establishing the diagnosis, as treatment varies dramatically by underlying pathology 5, 6
• For membranous nephropathy, observation for 6 months with conservative therapy is recommended before starting immunosuppression in most cases, as one-third will have spontaneous remission 5, 6
• Immunossuppression should be started earlier than 6 months if urinary protein excretion persistently exceeds 4 g/day, severe symptoms are present, serum creatinine rises by ≥30%, or high thrombotic risk is identified 5, 6
• First-line immunosuppression for membranous nephropathy is a 6-month course of alternating monthly cycles of oral and IV corticosteroids plus oral alkylating agents (cyclophosphamide or chlorambucil) 5, 6
• Alternative regimen for membranous nephropathy is cyclosporine or tacrolimus for ≥6 months if patient has contraindications to corticosteroids or refuses alkylating agents 6

Treatment Approach for Nephrotic Range Proteinuria

Immunosuppressive Treatment Strategy

• The European League Against Rheumatism, as reported by the Annals of the Rheumatic Diseases, recommends immunosuppressive treatment for active class III or IV lupus nephritis, with or without coexisting histological chronicity, and for pure class V lupus nephritis with nephrotic-range proteinuria 7
• The Annals of the Rheumatic Diseases suggests that proteinuria >1 g/24 hours despite optimal use of renin-angiotensin-aldosterone system blockers for at least 3 months is an alternative indication for immunosuppression in class V lupus nephritis 7
• The American College of Rheumatology, as aligned with the Annals of the Rheumatic Diseases, implies that the distinction between membranous nephropathy and lupus nephritis is critical because lupus nephritis requires immediate immunosuppression while membranous nephropathy typically warrants a 6-month observation period 7

Nephrotic Range Proteinuria Management

Diagnostic Approach and Conservative Management

• For patients with suspected secondary FSGS, a conservative management strategy including aggressive BP control, weight loss, and renin-angiotensin-aldosterone system inhibition should be started, as obesity, relatively normal serum albumin, and hilar histological variant suggest secondary FSGS 8
• Loop diuretics (furosemide) should be added for persistent edema despite ACE inhibitor and thiazide diuretics 8
• If proteinuria persists at 8-10 g/day despite 3-6 months of conservative therapy and lack of response to renin-angiotensin-aldosterone system inhibition, this points away from secondary FSGS and toward primary disease requiring immunosuppression 8

Evidence‑Based Recommendations for Nephrotic‑Range Proteinuria

Diagnosis and Clinical Decision‑Making

• Identifying whether nephrotic syndrome is primary (kidney‑limited) or secondary to a systemic disease is essential for selecting the appropriate treatment strategy in adults with nephrotic‑range proteinuria. 9

Conservative (Non‑Immunosuppressive) Management

• In patients diagnosed with membranous nephropathy, a minimum of six months of observation on optimized conservative therapy (e.g., renin‑angiotensin system blockade, lipid control, edema management) is recommended before initiating immunosuppressive agents. 10

Immunosuppressive Therapy Indications

• Lupus nephritis presenting with nephrotic‑range proteinuria mandates prompt initiation of immunosuppressive treatment rather than a period of observation. 9